Objective: Treating menorrhagia in women of reproductive age by endometrial ablation (EA) decreases menstrual flow and increases quality of life. However, unexpected pregnancy and associated complications are challenges following EA.
Materials And Methods: From January 2000 to March 2008, a total of 356 women aged 26-45 years with persistent menorrhagia underwent total hysteroresectoscopic EA with follow-up at our hospital and were retrospectively evaluated. We also performed a literature search for articles reporting pregnancy after EA published between January 1983 and June 2008.
Results: Overall, 123 pregnancies after EA have been reported in the English literature, including five pregnancies among 356 women who underwent EA at our hospital. Fifty-nine (48%) of 123 pregnancies were terminated at the mother's request. The remaining 64 pregnancies were associated with spontaneous abortion (28%, 17/64), premature rupture of membranes (16%, 10/64), prematurity (31%, 19/64), cesarean section (44%, 27/64), and placental adherence complications (25%, 17/64) which necessitating hysterectomy in 10 women. Four tubal ectopic, two cornual and two cervical ectopic pregnancies were reported. The ectopic pregnancy rate was 6.5% (8/123). There were nine perinatal deaths, corresponding to a perinatal mortality rate of 14% (9/64). Five babies had congenital anomalies, including craniosynostosis (1 case), a set of twins with Down syndrome (1 case), agenesis of the corpus callosum (1 case), bilateral talipes (1 case), and one case of fetal malformation caused by intrauterine synechiae. The only maternal death was a 29-year-old woman with spontaneous rupture of her unscarred uterus and massive intraabdominal hemorrhage at 24 weeks of gestation.
Conclusion: Clinicians must recognize the potential complications associated with pregnancy after EA. Appropriate postoperative contraception and follow-up of menstrual patterns are strongly recommended.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/S1028-4559(10)60067-8 | DOI Listing |
Front Physiol
December 2024
Department of Obstetrics and Gynecology, Deyang People's Hospital, Deyang, Sichuan, China.
Background: Recurrent pregnancy loss (RPL) poses significant challenges in clinical management due to an unclear etiology in over half the cases. Traditional screening methods, including ultrasonographic evaluation of endometrial receptivity (ER), have been debated for their efficacy in identifying high-risk individuals. Despite the potential of artificial intelligence, notably deep learning (DL), to enhance medical imaging analysis, its application in ER assessment for RPL risk stratification remains underexplored.
View Article and Find Full Text PDFBiomedicines
December 2024
Third Department of Obstetrics and Gynecology, Attikon Hospital, Medical School, National and Kapodistrian University of Athens, 1 Rimini, 124 62 Athens, Greece.
: Endometriosis is characterized by the presence of endometrial tissue outside the uterus. Beyond medical treatment, surgical intervention is also a viable consideration. However, current guidelines do not clearly indicate whether laparoscopic cystectomy, ablative methods (CO laser vaporization, plasma energy), or sclerotherapy is the preferred option.
View Article and Find Full Text PDFArch Gynecol Obstet
December 2024
Department of Obstetrics and Gynecology, Odense University Hospital, Kløvervænget 23, 5000, Odense, Denmark.
Objective: Endometrial resection and ablation are minimal invasive surgeries used to treat women with abnormal uterine bleeding (AUB). Both may be followed by a high reoperation rate up to 24%. However, some studies suggest that this may be improved by adding a levonorgestrel intrauterine device (LNG-IUD) immediately following surgery.
View Article and Find Full Text PDFJ Am Coll Radiol
December 2024
Assistant Professor, Interventional Radiology Residency Program Director, Division of Vascular and Interventional Radiology, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
Purpose: The aim of this study was to determine changes in procedural utilization for symptomatic uterine fibroids and adenomyosis from 2011 to 2020.
Methods: An institutional review board-exempt retrospective study of the National Inpatient Sample database from 2011 to 2020 was performed using International Classification of Diseases, Ninth Revision, and International Classification of Diseases, 10th Revision, diagnosis and procedural codes for uterine fibroids, adenomyosis, hysterectomy, myomectomy, uterine artery embolization (UAE), and endometrial ablation. Patients with endometriosis, uterine cancer, placenta accreta spectrum, pelvic inflammatory disease, and uterine prolapse were excluded.
J Osteopath Med
December 2024
Department of Medical and Surgical Gynecology, Mayo Clinic, Phoenix, AZ, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!